Skip to main content
profile image
Selected Works of Radleigh Santos
Presentation
Statistically significant association of glioblastoma immunotherapy phase II clinical study (ICT-107) treatment and survival to immune response using a novel comprehensive ELISPOT analysis.
Mathematics Faculty Proceedings, Presentations, Speeches, Lectures
  • Radleigh Santos, Torrey Pines Institute for Molecular Studies
  • Anthony Gringeri, ImmunoCellular Therapeutics Ltd
  • John Yu
  • Sylvia Janetzki, ZellNet Consulting
  • Valeria A. Judkowski, Torrey Pines Institute for Molecular Studies (TPIMS)
  • Clemencia Pinilla, Torrey Pines Institute for Molecular Studies
Event Name/Location
The 20th Annual Scientific Meeting and Education Day for the Society for Neuro-Oncology; 2015 November 19-22; San Antonio, TX
Document Type
Poster
Publication Date
11-1-2015
Disciplines
Citation Information
Radleigh Santos, Anthony Gringeri, John Yu, Sylvia Janetzki, et al.. "Statistically significant association of glioblastoma immunotherapy phase II clinical study (ICT-107) treatment and survival to immune response using a novel comprehensive ELISPOT analysis." (2015)
Available at: http://works.bepress.com/radleigh-santos/32/